|
Market Closed -
Australian S.E.
01:10:22 2026-10-23 am EDT
|
5-day change | 1st Jan Change | ||
| 7.120 AUD | +0.71% |
|
-5.82% | -42.86% |
| Market Cap | 359M 253M 226M 208M 189M 353M 23.97B 2.51B 993M 12.56B 948M 928M 39.6B | P/E 2027 * |
10.3x | P/E 2028 * | 9.94x |
|---|---|---|---|---|---|
| Enterprise Value | 75.94M 53.41M 47.69M 44.06M 39.93M 74.7M 5.07B 530M 210M 2.66B 200M 196M 8.37B | EV / Sales 2027 * |
0.8x | EV / Sales 2028 * | 0.43x |
| Free-Float |
83.53% | Yield 2027 * |
0.77% | Yield 2028 * | 0.83% |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| CUV | Delayed | |
Tradegate
| UR9 | Real-time | |
|
Boerse Muenchen
| UR9 | Real-time | |
|
Börse Stuttgart
| UR9 | Delayed | |
|
Deutsche Boerse AG
| UR9 | Delayed | |
|
OTC Markets
| CLVLF | Delayed |
Last Transcript: Clinuvel Pharmaceuticals Limited
| 1 day | +0.71% | ||
| 1 week | -5.82% | ||
| Current month | -17.21% | ||
| 1 month | -13.80% | ||
| 3 months | -29.22% | ||
| 6 months | -21.24% | ||
| Current year | -42.86% |
| 1 week | 6.62 |  | 7.68 |
| 1 month | 6.62 | | 8.6 |
| Current year | 6.62 | | 13.48 |
| 1 year | 6.62 | | 13.48 |
| 3 years | 6.62 | | 18.2 |
| 5 years | 6.62 | | 40.75 |
| 10 years | 5.91 | | 45.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Philippe Wolgen
CEO | Chief Executive Officer | 63 | 2005-10-31 |
Peter Vaughan
DFI | Director of Finance/CFO | 42 | 2024-06-29 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Karen Agersborg
BRD | Director/Board Member | - | 2018-01-28 |
Susan Smith
BRD | Director/Board Member | - | 2019-09-22 |
| Chairman | - | 2023-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/3/24 | Buy | Director | 8,333 | 0.0166% | ||
| 11/27/23 | Exercice | Chief Executive Officer | 301,125 | 0.6094% | ||
| 11/27/23 | Expiration | Chief Executive Officer | 1,513,750 | 3.0636% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.71% | -5.82% | -38.57% | -53.28% | 253M | |
| -2.54% | +1.31% | +54.27% | +114.96% | 1,135B | |
| -1.42% | +3.23% | +38.56% | +74.44% | 635B | |
| +0.16% | +0.08% | +25.29% | +95.23% | 505B | |
| -0.31% | +3.09% | +44.14% | +64.80% | 378B | |
| -1.34% | -0.47% | +66.04% | +41.00% | 358B | |
| -0.68% | +2.65% | +22.98% | +50.39% | 295B | |
| -1.20% | +3.04% | +2.33% | +22.86% | 266B | |
| -1.79% | +1.57% | +50.56% | +59.08% | 237B | |
| -0.73% | -0.10% | +29.02% | +99.67% | 193B | |
| Average | -0.91% | +1.37% | +29.46% | +56.91% | 400.39B | |
| Weighted average by Cap. | -1.35% | +2.66% | +41.02% | +79.74% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 94.47M 66.44M 59.34M 54.81M 49.67M 92.93M 6.31B 660M 261M 3.3B 249M 244M 10.42B | 100M 70.6M 63.04M 58.24M 52.78M 98.74M 6.7B 701M 277M 3.51B 265M 259M 11.07B |
| Net income | 34.94M 24.57M 21.95M 20.27M 18.37M 34.37M 2.33B 244M 96.59M 1.22B 92.23M 90.26M 3.85B | 36.32M 25.55M 22.81M 21.07M 19.1M 35.73M 2.42B 254M 100M 1.27B 95.87M 93.83M 4.01B |
| Net Debt | -283M -199M -178M -164M -149M -279M -18.9B -1.98B -783M -9.9B -747M -731M -31.22B | -316M -222M -198M -183M -166M -310M -21.07B -2.2B -872M -11.04B -833M -815M -34.81B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | A$7.120 | +0.71% | 193,862 |
| 26-10-22 | A$7.070 | -4.20% | 348,822 |
| 26-10-21 | A$7.380 | -1.07% | 201,954 |
| 26-10-20 | A$7.460 | -0.80% | 466,555 |
| 26-10-19 | A$7.520 | -0.53% | 111,534 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CUV Stock
Select your edition
All financial news and data tailored to specific country editions
